腸内微生物群をプロおよびポストバイオティクスで標的にする:脱毛症に対する新興戦略
Vijay Singh1, Md Sadique Hussain2, Joy Das3
1Department of Medical Laboratory Technology, School of Allied Health Sciences, Galgotias University, Plot No. 2, Sector 17-A, Yamuna Expressway, Greater Noida, Gautam Buddha Nagar, Uttar Pradesh, 203201, India.
Probiotics and antimicrobial proteins
|February 18, 2026
まとめ
腸内微生物群は,炎症と栄養素吸収を通して,脱毛 (脱毛症) に影響します. プロバイオティクスを用いて腸内細菌を標的とし,その他の介入を行うことは,新しい脱毛症治療の有望性を示しています.
科学分野:
- マイクロバイオームの研究
- 皮膚科 皮膚科について
- 免疫学 免疫学とは
背景:
- 脱毛症は,遺伝,ホルモン,免疫,環境の影響を受ける複雑な脱毛状態です.
- 腸毛軸は,腸内微生物群と全身免疫,酸化ストレス,栄養素の供給を結びつけています.
- 腸内不活性症は炎症と毛皮の機能不全に寄与し,脱毛症を悪化させます.
研究 の 目的:
- 脱毛症における腸毛軸の役割を調査する.
- 脱毛症の治療のための微生物群を標的とした介入の見直しをすること.
- 髪の健康のために腸内微生物群を調節する可能性を強調するために.
主な方法:
- 腸毛軸と脱毛症に関する臨床前および早期臨床研究のレビュー.
- 腸の機能不全が毛皮のサイクリングに与える影響の分析.
- プロバイオティクス,プレバイオティクス,ポストバイオティクス,シンバイオティクス,パラバイオティクスを含む治療戦略の調査.
主要な成果:
- 腸内不活性症は,炎症の増加と障壁機能の低下と関連しており,毛皮に悪影響を及ぼします.
- 特定のプロバイオティック菌株 (ラクトバシルス,ビフィドバクテリア) は,免疫調節および抗酸化効果を示しています.
- SCFAやバクテリオシンなどのポストバイオティック代謝産物は,抗炎症性および細胞保護性効果を示しています.
結論:
- 腸内微生物群を調節することで,脱毛症に対する新しい治療法が提供されます.
- プロバイオティクスやポストバイオティクスのような介入は,臨床前および臨床初期での可能性を示しています.
- マイクロバイオタを標的とした脱毛症の治療法を検証するために,さらなるランダム化対照試験が必要である.
関連する概念動画
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
940
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
940
Inflammatory Bowel Disease IV: Pharmacological Management
817
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
817
Microorganisms in Medicine and Therapeutics
1.2K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.2K
Biological Methods for Microbial Control
938
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
938
What is Monogastric Digestion?
76.0K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
76.0K


